Some studies have found that circ FOXP1 was significantly overexpressed in the serum of NSCLC patients [159], and the down-regulation of circ FOXP1 can inhibit the proliferation of lung cancer cells [160, 161]. This evidence concerns the gene FOXP1 and lung cancer.